Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Celgene and Array sign second option deal, Array gets $11mm to start

Executive Summary

Celgene Corp. and Array BioPharma Inc. (therapies for cancer and inflammatory diseases) have teamed up again, in their second collaboration since 2007. This time, Celgene gets an exclusive option to license some of Array’s preclinical projects targeting an undisclosed inflammatory pathway.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Intra-Biotech Deal
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register